Current Neuro-Oncology
Volume
26 Number 30
31 December 2024
Home > Publications > Current Neuro-Oncology > Volume 26, Year 2024 > Number 30, 31 December
Matsunaga S, Kimura Y, Akiyama Y, Yamamoto
M, Mikuni N.
Congenital
extraventricular neurocytoma with atypical features in a 3-day-old
neonate.
Childs
Nerv Syst. 2024 Dec 21;41(1):64.
doi:
10.1007/s00381-024-06725-w. PMID:
39708128. Case report˰
ˍ
*Eun J, Um YH, Han K, Joo WI, Yang SH.
The
impact of depression on risk of malignant glioma: A nationwide
cohort study.
J
Psychosom Res. 2024 Dec 22;189:111982. doi:
10.1016/j.jpsychores.2024.111982. PMID:
39729890. Observational study. ˍ
Yamaguchi J, Ohka F, Motomura K, Ishizaki T, Nakahara N, Fujitani
S, Nagatani T, Ohno M, Ando M, Kuwatsuka Y, Nishida K, Saito R.
A
multi-center, open-label, randomized clinical trial evaluating the
preventive effect of perampanel on craniotomy-induced
epileptogenesis in seizure-naive patients
with supratentorial brain tumors: study protocol for a GRAMPAS
trial.
Trials.
2024 Dec 24;25(1):849. doi:
10.1186/s13063-024-08693-7. PMID:
39716271. Interventional study protocol. ˍ
Thavaneswaran S, Sim HW, Grady J, Espinoza D, Huang ML, Lin F,
McGrath M, Desai J, Charakidis M, Brown M, Kansara M, Simes J,
Thomas D.
A phase II trial of
larotrectinib in tumors with NTRK fusions or extremes of NTRK mRNA
overexpression identified by comprehensive genomic profiling.
Oncologist.
2024 Dec 25:oyae339. doi:
10.1093/oncolo/oyae339. PMID:
39720993. Interventional study. ˍ
Aziz N, Waqar U, Bukhari MM, Uzair M, Ahmed S, Naz H, Shamim MS.
Blood transfusions in craniotomy for
tumor resection: Incidence, risk factors, and outcomes.
J
Clin Neurosci. 2024 Dec 26;132:111009. doi:
10.1016/j.jocn.2024.111009. PMID:
39732040. Observational study˰
ˍ
Gao K, Zhou T, Yin Y, Sun X, Jiang H, Li T.
Atorvastatin
inhibits glioma glycolysis and immune escape by modulating the
miR-125a-5p/TXLNA axis.
Hereditas.
2024 Dec 26;161(1):54. doi:
10.1186/s41065-024-00349-5. PMID:
39726023. Laboratory investigation. ˍ
Gould A, Luan Y, Hou Y, Korobova FV, Chen L, Arrieta VA, Amidei C,
Ward R, Gomez C, Castro B, Habashy K, Zhang D, Youngblood M,
Dmello C, Bebawy J, Bouchoux G, Stupp R, Canney M, Yue F,
Iruela-Arispe ML, Sonabend AM.
Endothelial
Response to Blood-Brain Barrier Disruption in the Human Brain.
JCI
Insight. 2024 Dec 26:e187328. doi:
10.1172/jci.insight.187328. PMID:
39724015. Interventional study. ˍ
Nyabuto E, Fenstermaker RA, Qiu J.
Secondary
IDH-mutant gliosarcoma in a patient with prior IDH-mutant grade 2
astrocytoma.
J
Neuropathol Exp Neurol. 2024 Dec 26:nlae131. doi:
10.1093/jnen/nlae131. PMID:
39724916. Case report˰
ˍ
Yang L, Xie X, Zhang J, Luo C, Bu L, Wu S, Deng W, Yao Y, Zhang X,
Chen H.
Non-enhancing margin and pial
invasion in MRI can predict IDH status in glioma patients.
World
Neurosurg. 2024 Dec 26:123624? doi: 10.1016/j.wneu.2024.123624?
PMID:
39732457. Observational study˰
ˍ
Pasquini L, Napolitano A, Spitoni L, Schmid M, Dellepiane F,
Jenabi M, Peck KK, Holodny AI.
Cognitive
Control Network and Language Reorganization in Patients with Brain
Tumors.
AJNR
Am J Neuroradiol. 2024 Dec 27:ajnr.A8638. doi:
10.3174/ajnr.A8638. PMID:
39730156. Observational study˰
ˍ
Grin K, Azizi A, Haberler C,
Peyrl A, Kasprian G, Czech T, Rössler K, Gojo J, Dorfer C.
Cerebellar
pilocytic astrocytoma: predictors of recurrence based on MRI
morphology-a single-centre experience.
Childs
Nerv Syst.
2024 Dec 28;41(1):73. doi:
10.1007/s00381-024-06733-w. PMID:
39733051. Observational study. ˍ
Kaushal-Deep SM, Bhat AR, Fayaz M, Scalia G, Robbani I, Wani MA,
Lodhi M, Chaurasia B.
Intraoperative
variations in intra-axial brain tumor size after craniotomy: a
prospective study with histopathological and tumor tissue
composition correlation, introducing concepts of tumor expansion
and tumor surfacing.
Neurosurg
Rev. 2024 Dec 28;48(1):9. doi:
10.1007/s10143-024-03157-7. PMID:
39730869. Observational study˰
ˍ
Lesueur P, Clarisse B, Lequesne J, Licaj I, Feuvret L, Stefan D,
Ricard D, Noel G, Balosso J, Lange M, Capel A, Durand-Zaleski I,
Castera M, Legrand B, Goliot N, Hedou C, Grellard JM, Valable S.
Proton therapy versus conventional
radiotherapy for the treatment of
cavernous sinus benign meningioma, a
randomized controlled phase III study
protocol (COG-PROTON-01).
BMC
Cancer. 2024 Dec 30;24(1):1594. doi:
10.1186/s12885-024-13353-9. PMID:
39736544. Interventional study protocol. ˍ
McFaline-Figueroa JR, Sun L, Youssef GC, Huang R, Li G, Kim J, Lee
EQ, Nayak L, Chukwueke U, Beroukhim R, Batchelor TT, Chiocca EA,
Everson RG, Doherty L, Stefanik J, Partridge K, Spearman A, Myers
A, Westergaard C, Russ A, Lavallee M, Smokovich A, LaForest-Roys
C, Garcia Fox R, McCluskey C, Bi WL, Arnaout O, Peruzzi P,
Cosgrove GR, Ligon KL, Arrillaga-Romany I, Clarke JL, Reardon DA,
Cloughesy TF, Prins RM, Wen PY.
Neoadjuvant
anti-PD1 immunotherapy for surgically
accessible recurrent glioblastoma: clinical and molecular outcomes
of a
stage 2 single-arm expansion cohort.
Nat
Commun. 2024 Dec 30;15(1):10757. doi:
10.1038/s41467-024-54326-7. PMID:
39737895. Interventional study. ˍ
Wang F, Dong J, Xu Y, Jin J, Xu Y, Yan X, Liu Z, Zhao H, Zhang J,
Wang N, Hu X, Gao X, Xu L, Yang C, Ma S, Du J, Hu Y, Ji H, Hu S.
Turning attention to
tumor-host interface and focus on the
peritumoral heterogeneity of glioblastoma.
Nat
Commun. 2024 Dec 30;15(1):10885. doi:
10.1038/s41467-024-55243-5. PMID:
39738017. Laboratory investigation. ˍ
Fattahi E, Kankam SB, Khoshnevisan A, Hashemi AP.
Evaluating
prognosis and survival
in patients with glioblastoma in contact with subventricular zone:
Tumor location and its correlation
with prognosis.
Med
J Armed Forces India. 2022 Aug 19;80(Suppl 1):S21-S28.
doi:
10.1016/j.mjafi.2022.06.012. PMID:
39734827. Observational study˰
ˍ
Mendez JS, Cohen AL, Eckenstein M, Jensen RL, Burt LM, Salzman KL,
Chamberlain M, Hsu HH, Hutchinson M, Iwamoto F, Ligon KL, Mrugala
MM, Pelayo M, Plotkin SR, Puduvalli VK, Raizer J, Reardon DA,
Sterba M, Walbert T, West BL, Wong ET, Zhang C, Colman H.
Phase
1b/2 study of orally administered pexidartinib in combination with
radiation therapy and temozolomide in patients with newly
diagnosed glioblastoma.
Neurooncol
Adv. 2024 Nov 22;6(1):vdae202. doi:
10.1093/noajnl/vdae202. PMID:
39734810. Interventional study. ˍ
Nago B, Liu JE.
An unusual case of
varicella zoster encephalitis mimicking a glioblastoma on magnetic
resonance imaging and magnetic resonance spectroscopy.
IDCases.
2024 Dec 4;39:e02124. doi:
10.1016/j.idcr.2024.e02124. PMID:
39720100. Case report. ˍ
Dmello C, Brenner A, Piccioni D, Wen PY, Drappatz J, Mrugala M,
Lewis LD, Schiff D, Fadul CE, Chamberlain M, Kesari S, Ahluwalia
M, Ghosh D, Sonabend AM, Kumthekar P.
Phase
II trial of blood-brain barrier permeable peptide-paclitaxel
conjugate ANG1005 in patients with recurrent high-grade
glioma.
Neurooncol
Adv. 2024 Dec 14;6(1):vdae186. doi:
10.1093/noajnl/vdae186. PMID:
39713041. Interventional study. ˍ
Bauchet L, Rigau V, Mathon B, Darlix A; With the participation of
the Société Française de Neurochirurgie
(SFNC), Club de Neuro-oncologie of SFNC, Société
Française de Neuropathologie (SFNP) and Association des
Neuro-Oncologues d’Expression Française (ANOCEF).
Epidemiological analysis of adult-type
diffuse lower-grade gliomas and incidence and prevalence estimates
of diffuse IDH-mutant gliomas in France.
Neurochirurgie.
2024 Dec 20:101627. doi:
10.1016/j.neuchi.2024.101627. PMID:
39710298. Observational study. ˍ
Duan H, He Z, Chen Z, Chen Y, Hu W, Sai K, Zhang X, Xia J, Li Y,
Liu R, Zou C, Chen Z, Mou Y.
Long-term
survival after local immunotherapy for malignant gliomas: a
retrospective study with 20 years follow-up.
BMC
Immunol. 2024 Dec 20;25(1):83. doi:
10.1186/s12865-024-00676-2. PMID:
39707189. Observational study. ˍ